HEALTH - Cervical cancer caused by Human Papilloma Virus (HPV) is the only cancer that can be prevented by vaccination. The HPV vaccine was shown to prevent cervical cancer and other cancers caused by the virus.
Government plans a HPV vaccine into the national immunization program for female students in class V (first dose) and VI (second dose) SD / MI and equal. This means that the HPV vaccine would like to put dalan School Children Immunization Month program (BIAS).
Head of Communications and Human Services Oscar Primadi in statement reveals, HPV immunization activities through BIAS program is started from the fifth grade elementary school students in Jakarta.
Jakarta became pilot areas because of cervical cancer cases is quite high and the province is considered to have been ready to carry out HPV immunization.
"Implementation of HPV immunization in the Immunization of School Children Month activities (BIAS) in Jakarta is already getting recommendations from the National Advisory Committee on Immunization Expert (Indonesian Technical Advisory Group on Immunization)," said Oscar.
The first dose, ie in grade V SD conducted in October 2016. Once in Jakarta, HPV vaccine will also be continued in two districts in the province of Yogyakarta, namely Kulon Progo and Gunung Kidul in the next year.
It is unfortunate the outstanding issue of the HPV vaccine given to elementary school in Jakarta will cause premature menopause to infertility. The wrong information may make parents worry and cervical cancer prevention measures even inhibited.
In fact, HPV is very useful to prevent children developing cervical cancer as adults later.
Earlier, Chairman of the Indonesian Working Group on HPV, Prof. Dr. Dr. Andrijono, SpOG (K) hope, the HPV vaccine will be included in the program BIAS.
Vaccine in children aged 9-12 years are considered more effective because the antibodies or immunity against HPV virus is more optimal.
HPV vaccine obtaining marketing authorization the first time since 2006. Since then, more than 200 million doses of vaccine used throughout the world. So far there has never been any security problems in the use of the HPV vaccine.
A number of countries have been using the HPV vaccine to suppress cases of cervical cancer. WHO has also recommended that the HPV vaccine into the national immunization program.
